GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of tried MASH for 15 weeks. here is what happened. — 22 comments in the full submission. View in context.
611
c/survodutide·submitted 3 months ago by u/meera_sandvik

tried MASH for 15 weeks. here is what happened.

Trial Databranch of 5 comments

Long-ish post, sorry. tl;dr at the bottom. I have been tracking survodutide against ApoB for 31 weeks because I could not find anyone who had. The correlation is weaker than I expected, which is itself mildly interesting given how confidently people link the two in here. Caveats up front: one person, one lab, one…

Read the full submission and all 22 comments →

This branch

5 comments, started 3 months ago
u/liver_enzyme_liz12 points·3 months ago
it is in the wiki actually
replysharereportpermalink
u/cato_girard5 points·3 months ago

the MASH indication changes the risk calculus

replysharereportpermalink
u/meera_sandvikOP4 points·3 months ago

rodent dual agonist is investigation only

replysharereportpermalink
u/cato_batista3 points·3 months ago

the safety profile is not just tirzepatide amplified

replysharereportpermalink
u/meera_sandvikOP1 point·3 months ago

Came off after 5 weeks for financial reasons. Regained about a third over the following year. Back on now at a much lower dose.

replysharereportpermalink

← back to the whole thread

About c/survodutide

Survodutide-specific discussion: glucagon-receptor co-agonism, the hepatic fat and MASH resolution data, and how the side-effect profile compares with GIP-based dual agonism. Small community, high signal.

12kmembers
62submissions
Feb 2024created
submissions / month, last year
Sponsored

PeptideMeter Analytics

Independent testing plus vendor-level trend data. Community-funded, unaffiliated.

peptidemeter.com
c/survodutide rules
  1. Glucagon co-agonism has a distinct safety story. Do not generalise from tirzepatide.
  2. MASH claims need the trial and the biopsy endpoint.
  3. Not approved. Descriptive posts only.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.